Anavex Life Sciences Corp (AVXL)

[gburgin]

sokol, the original greek patent for 2-73 was granted in 1996 and I thought the others were granted a few years later? I would think if you add the current time for 2-73 AD approval + 5 years of FDA exclusivity, you'd be out near or past the expiration of all those Greek patents. Could there be any meat left on those bones?
Also regarding the dormant patent. I recall an old Orveko post where he was discussing why that patent had not been reactivated given it's relevance to the current trial. I believe he said the original patent was broader than just a composition of matter patent and that it went into "use" as an AD treatment. I believe he said that may be gating the activation of the dormant patent.